Asiimwe IG, Pirmohamed M. Drug–drug–gene interactions in cardiovascular medicine. Pharmacogenomics Pers Med. 2022;15:879–911. https://doi.org/10.2147/PGPM.S338601.

Article  CAS  Google Scholar 

Tibaut M, Caprnda M, Kubatka P, Sinkovič A, Valentova V, Filipova S, et al. Markers of atherosclerosis: part 2 – genetic and imaging markers. Heart Lung Circ. 2019;28:678–89. https://doi.org/10.1016/j.hlc.2018.09.006.

Article  PubMed  Google Scholar 

Damiani I, Solberg EH, Iyer M, Cheng P, Weldy CS, Kim JB. Environmental pollutants and atherosclerosis: epigenetic mechanisms linking genetic risk and disease. Atherosclerosis. 2025;404:119131. https://doi.org/10.1016/j.atherosclerosis.2025.119131.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peterlin A, Petrovič D, Peterlin B. Screening for rare genetic variants associated with atherosclerosis: opportunity for personalized medicine. Curr Vasc Pharmacol. 2018;17:25–8. https://doi.org/10.2174/1570161116666180206111725.

Article  CAS  Google Scholar 

Radhakrishnan A, Kuppusamy G, Ponnusankar S, Shanmukhan NK. Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery. Pharmacogenomics J. 2020;20:1–18. https://doi.org/10.1038/s41397-019-0135-8.

Article  CAS  PubMed  Google Scholar 

Mauriello A, Ascrizzi A, Molinari R, Falco L, Caturano A, D’Andrea A, et al. Pharmacogenomics of cardiovascular drugs for atherothrombotic, thromboembolic and atherosclerotic risk. Genes (Basel). 2023;14:2057. https://doi.org/10.3390/genes14112057.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, et al. Pathophysiology of atherosclerosis. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms23063346

Insull W. The pathology of atherosclerosis: Plaque development and plaque responses to medical treatment. Am J Med. 2009;122. https://doi.org/10.1016/j.amjmed.2008.10.013

Borén J, Williams KJ. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr Opin Lipidol. 2016: 473–83. https://doi.org/10.1097/MOL.0000000000000330

Mauriello A, Correra A, Maratea AC, Caturano A, Liccardo B, Perrone MA, et al. Serum lipids, inflammation, and the risk of atrial fibrillation: pathophysiological links and clinical evidence. J Clin Med. 2025;14:1652. https://doi.org/10.3390/jcm14051652.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Llorente-Cortés V, Martínez-González J, Badimon L. LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2000;20:1572–9. https://doi.org/10.1161/01.ATV.20.6.1572.

Article  PubMed  Google Scholar 

Goldstein JL, Brown MS. A century of cholesterol and coronaries: from plaques to genes to statins. Cell. 2015: 161–72. https://doi.org/10.1016/j.cell.2015.01.036

Russo V, Falco L, Tessitore V, Mauriello A, Catapano D, Napolitano N, et al. Anti-inflammatory and anticancer effects of anticoagulant therapy in patients with malignancy. Life. 2023;13:1888. https://doi.org/10.3390/LIFE13091888.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mauriello A, Maratea AC, Fonderico C, Quagliariello V, Maurea F, Maurea N. Factor XI and cancer: physiopathological linkage and clinical perspectives. J Clin Med. 2025;14:6341. https://doi.org/10.3390/jcm14176341.

Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114:1852–66. https://doi.org/10.1161/CIRCRESAHA.114.302721.

Article  CAS  PubMed  Google Scholar 

Asada Y, Yamashita A, Sato Y, Hatakeyama K. Pathophysiology of atherothrombosis: mechanisms of thrombus formation on disrupted atherosclerotic plaques. Pathol Int. 2020:309–22. https://doi.org/10.1111/pin.12921

Anlamlert W, Lenbury Y, Bell J. Modeling fibrous cap formation in atherosclerotic plaque development: stability and oscillatory behavior. Adv Differ Equ. 2017;2017. https://doi.org/10.1186/s13662-017-1252-9

Yu Y, Cai Y, Yang F, Yang Y, Cui Z, Shi D, et al. Vascular smooth muscle cell phenotypic switching in atherosclerosis. Heliyon. 2024. https://doi.org/10.1016/j.heliyon.2024.e37727.

Article  PubMed  PubMed Central  Google Scholar 

Mauriello A, Correra A, Molinari R, Del Vecchio GE, Tessitore V, D’Andrea A, et al. Mitochondrial dysfunction in atrial fibrillation: the need for a strong pharmacological approach. Biomedicines. 2024;12:2720. https://doi.org/10.3390/biomedicines12122720.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Paoli F, Staels B, Chinetti-Gbaguidi G, Japanese Circulation Society. Macrophage phenotypes and their modulation in atherosclerosis. Circ J. 2014. https://doi.org/10.1253/circj.CJ-14-0621.

Article  PubMed  Google Scholar 

Russo V, Napolitano N, Ascrizzi A, Leonardi S, Pisacane F, Di Micco P, et al. The lipid-lowering efficacy of a nutraceutical combination including leucoselect phytosome, red yeast rice, policosanol and folic acid in dyslipidaemia patients: real-world insights. Pharmaceuticals. 2024;17:447. https://doi.org/10.3390/ph17040447.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gimbrone MA, García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res Lippincott Williams and Wilkins. 2016;118:620–36. https://doi.org/10.1161/CIRCRESAHA.115.306301.

Article  CAS  Google Scholar 

Mauriello A, Del GC, Del VGE, Correra A, Maratea AC, Grieco M, et al. Takotsubo syndrome and oxidative stress: physiopathological linkage and future perspectives. Antioxidants. 2025;14:522. https://doi.org/10.3390/antiox14050522.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davis ME, Grumbach IM, Fukai T, Cutchins A, Harrison DG. Shear Stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor κB binding. J Biol Chem. 2004;279:163–8. https://doi.org/10.1074/jbc.M307528200.

Article  CAS  PubMed  Google Scholar 

Wong ND, Budoff MJ, Ferdinand K, Graham IM, Michos ED, Reddy T, et al. Atherosclerotic cardiovascular disease risk assessment: an American Society for Preventive Cardiology clinical practice statement. Am J Prev Cardiol. 2022;10. https://doi.org/10.1016/j.ajpc.2022.100335

Visseren F, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021:3227–337. https://doi.org/10.1093/eurheartj/ehab484

Vernon ST, Sci M, Coffey S, D’souza M, Chow CK, Kilian J, et al. ST-Segment-Elevation Myocardial Infarction (STEMI) patients without standard modifiable cardiovascular risk factors-how common are they, and what are their outcomes?. https://doi.org/10.1161/JAHA

Tada H, Takamura M, Kawashiri MA. Familial hypercholesterolemia: A narrative review on diagnosis and management strategies for children and adolescents. Vasc Health Risk Manag. 2021:59–67. https://doi.org/10.2147/VHRM.S266249

McGowan MP, Hosseini Dehkordi SH, Moriarty PM, Duell PB. Diagnosis and treatment of heterozygous familial hypercholesterolemia. J Am Heart Assoc. 2019;8. https://doi.org/10.1161/JAHA.119.013225

Santos RD, Cuchel M. LDL-C-lowering therapies for adults and children with homozygous familial hypercholesterolemia: challenges and successes. Circulation. 2024:363–6. https://doi.org/10.1161/CIRCULATIONAHA.123.067241

Mauriello A, Correra A, Maratea AC, Benfari G, Ilardi F, Giugliano G, et al. Radiation-Induced Carotid Artery Disease: Pathogenesis, Diagnosis and Management. Diagnostics. 2026;16:841 https://doi.org/10.3390/diagnostics16060841

Aragam KG, Natarajan P. Polygenic scores to assess atherosclerotic cardiovascular disease risk: clinical perspectives and basic implications. Circ Res. 2020;126:1159–77. https://doi.org/10.1161/CIRCRESAHA.120.315928.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schork NJ, Murray SS, Frazer KA, Topol EJ. Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 2009:212–9. https://doi.org/10.1016/j.gde.2009.04.010

So HC, Sham PC, Valencia A. Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits. Bioinformatics. 2017;33:886–92. https://doi.org/10.1093/bioinformatics/btw745.

Article  CAS  PubMed  Google Scholar 

Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, Roos C, et al. Polymorphisms associated with cholesterol and risk of cardiovascular events abstract. N Engl J Med. 2008. www.nejm.org

Inouye M, Abraham G, Nelson CP, Wood AM, Sweeting MJ, Dudbridge F, et al. Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention. J Am Coll Cardiol Elsevier USA. 2018;72:1883–93. https://doi.org/10.1016/j.jacc.2018.07.079.

Article  Google Scholar 

Natarajan P. Polygenic risk scoring for coronary heart disease: the first risk factor. J Am Coll Cardiol. 2018:1894–7. https://doi.org/10.1016/j.jacc.2018.08.1041

Pillutla V, Aragam KG. Polygenic scores in real-world cardiovascular risk prediction: the path forward for assessing worth? Eur Heart J. 2024:3161–3. https://doi.org/10.1093/eurheartj/ehae442

Christiansen MK, Nissen L, Winther S, Møller PL, Frost L, Johansen JK, et al. Genetic risk of coronary artery disease, features of atherosclerosis, and coronary plaque burden. J Am Heart Assoc. 2020;9. https://doi.org/10.1161/JAHA.119.014795

Levin MG, Kember RL, Judy R, Birtwell D, Williams H, Arany Z, et al. Genomic Risk Stratification Predicts All-Cause Mortality After Cardiac Catheterization. Circ Genom Precis Med. 2018;11:e002352. https://doi.org/10.1161/CIRCGEN.118.002352.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schunkert H, Di Angelantonio E, Inouye M, Patel RS, Ripatti S, Widen E, et al. Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease a clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive Cardiology. Eur Heart J Oxford University Press. 2025;46:1372–83. https://doi.org/10.1093/eurheartj/ehae649.

Article  CAS  Google Scholar 

Ferri N, Corsini A, Bellosta S. Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties. Drugs. 2013;73:1681–709. https://doi.org/10.1007/s40265-013-0126-z.